Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MRPL.NS Stock Summary
In the News
MRPL.NS Financial details
Company Rating
Buy
Market Cap
388.9B
Income
43.72B
Revenue
904.81B
Book val./share
68.08
Cash/share
0.21
Dividend
-
Dividend %
-
Employees
2.55K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
6.22
Forward P/E
-
PEG
1.3
P/S
0.25
P/B
1.97
P/C
1097.38
P/FCF
-
Quick Ratio
0.33
Current Ratio
1.07
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
24.95
EPS next Y
-
EPS next Q
-
EPS this Y
-10.25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
50.84%
Revenue last 5Y
11.5%
Revenue Q/Q
28.33%
EPS Q/Q
-62.67%
-
-
-
-
SMA20
4.94%
SMA50
27%
SMA100
97.86%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
69%
ROC
0.35%
Gross Margin
11%
Oper. Margin
9%
Profit Margin
4%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
52.85-289.25
52W High
-20.26%
52W Low
+343.17%
RSI
54.41
Rel Volume
0.1
Avg Volume
9.66M
Volume
938.21K
Perf Week
-3.27%
Perf Month
0.57%
Perf Quarter
137.7%
Perf Half Y
122.76%
-
-
-
-
Beta
1.055
-
-
Volatility
3.86%, 10.76%
Prev Close
2.24%
Price
230.45
Change
3.53%
MRPL.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 360.46 | 287.41 | 180.59 | 398.18 | 621.11 | |
Net income per share | 1.94 | -19.13 | -3.24 | 16.88 | 15.15 | |
Operating cash flow per share | 6.86 | 2.72 | -15.99 | 26.78 | 36.31 | |
Free cash flow per share | 1.36 | -5.8 | -21.2 | 23.29 | 32.3 | |
Cash per share | 0.23 | 0.01 | 0.3 | 0.29 | 0.22 | |
Book value per share | 56.75 | 39 | 24.24 | 41.14 | 56.29 | |
Tangible book value per share | 56.28 | 38.21 | 22.04 | 38.95 | 54.1 | |
Share holders equity per share | 56.75 | 39 | 24.24 | 41.14 | 56.29 | |
Interest debt per share | 93.54 | 107.38 | 142.07 | 123.94 | 103.98 | |
Market cap | 130.13B | 40.57B | 68.09B | 72.91B | 92.1B | |
Enterprise value | 286.26B | 219.99B | 308.45B | 285.96B | 261.42B | |
P/E ratio | 38.27 | -1.21 | -12 | 2.46 | 3.47 | |
Price to sales ratio | 0.21 | 0.08 | 0.22 | 0.1 | 0.08 | |
POCF ratio | 10.82 | 8.5 | -2.43 | 1.55 | 1.45 | |
PFCF ratio | 54.62 | -3.99 | -1.83 | 1.79 | 1.63 | |
P/B Ratio | 1.31 | 0.59 | 1.6 | 1.01 | 0.93 | |
PTB ratio | 1.31 | 0.59 | 1.6 | 1.01 | 0.93 | |
EV to sales | 0.45 | 0.44 | 0.97 | 0.41 | 0.24 | |
Enterprise value over EBITDA | 11.73 | -6.43 | 28.96 | 6.75 | 3.89 | |
EV to operating cash flow | 23.8 | 46.07 | -11.01 | 6.09 | 4.11 | |
EV to free cash flow | 120.16 | -21.65 | -8.3 | 7.01 | 4.62 | |
Earnings yield | 0.03 | -0.83 | -0.08 | 0.41 | 0.29 | |
Free cash flow yield | 0.02 | -0.25 | -0.55 | 0.56 | 0.61 | |
Debt to equity | 1.57 | 2.63 | 5.66 | 2.96 | 1.72 | |
Debt to assets | 0.48 | 0.59 | 0.69 | 0.53 | 0.48 | |
Net debt to EBITDA | 6.4 | -5.25 | 22.57 | 5.03 | 2.52 | |
Current ratio | 0.55 | 0.57 | 0.73 | 0.86 | 0.99 | |
Interest coverage | 2.48 | -3.84 | -0.68 | 9.98 | 5.19 | |
Income quality | 3.42 | -0.12 | 3.66 | 1.59 | 2.4 | |
Dividend Yield | 0.05 | 0.05 | 0 | 0 | 0 | |
Payout ratio | 1.86 | -0.06 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.8 | -3.13 | 0.33 | -0.13 | -0.11 | |
Capex to revenue | -0.02 | -0.03 | -0.03 | -0.01 | -0.01 | |
Capex to depreciation | -0.92 | -1.38 | -0.79 | -0.56 | -0.59 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 49.77 | 129.56 | 42.02 | 124.99 | 138.52 | |
ROIC | 0.04 | -0.1 | -0.02 | 0.16 | 0.15 | |
Return on tangible assets | 0.01 | -0.11 | -0.02 | 0.07 | 0.08 | |
Graham Net | -94.88 | -114.93 | -140.08 | -136.16 | -104.85 | |
Working capital | -79.83B | -45.33B | -38.64B | -25.26B | -1.34B | |
Tangible asset value | 98.63B | 66.97B | 38.62B | 68.26B | 94.82B | |
Net current asset value | -125.97B | -175.95B | -202.51B | -174.31B | -133.65B | |
Invested capital | 1.57 | 2.63 | 5.66 | 2.96 | 1.72 | |
Average receivables | 34.11B | 26.62B | 24.15B | 40.2B | 47.87B | |
Average payables | 47.43B | 39.85B | 38.03B | 68.48B | 77.68B | |
Average inventory | 57.75B | 52.7B | 56.68B | 87.95B | 86.32B | |
Days sales outstanding | 20.77 | 12.53 | 35.76 | 25.83 | 15.55 | |
Days payables outstanding | 28.47 | 22.88 | 51.56 | 53.39 | 22.55 | |
Days of inventory on hand | 38.27 | 29.56 | 84.6 | 59.77 | 24.77 | |
Receivables turnover | 17.57 | 29.13 | 10.21 | 14.13 | 23.48 | |
Payables turnover | 12.82 | 15.95 | 7.08 | 6.84 | 16.19 | |
Inventory turnover | 9.54 | 12.35 | 4.31 | 6.11 | 14.74 | |
ROE | 0.03 | -0.49 | -0.13 | 0.41 | 0.27 | |
Capex per share | -5.5 | -8.52 | -5.22 | -3.49 | -4.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 151.53 | 144.93 | 120.81 | 109.72 | 140.8 | |
Net income per share | -1.11 | 10.92 | 5.79 | 6 | 2.24 | |
Operating cash flow per share | 3.4 | 3.38 | 3.36 | 3.38 | 3.81 | |
Free cash flow per share | 3.4 | 3.38 | 3.36 | 3.38 | 3.81 | |
Cash per share | 0.22 | 0.22 | 0.22 | 0.25 | 0.21 | |
Book value per share | 46.49 | 56.29 | 56.29 | 68.08 | 68.08 | |
Tangible book value per share | 0 | 54.1 | 0 | 65.9 | 0 | |
Share holders equity per share | 46.49 | 56.29 | 56.29 | 68.08 | 68.08 | |
Interest debt per share | 1.93 | 98.53 | 1.53 | 82.84 | 1.56 | |
Market cap | 98.32B | 92.1B | 135.04B | 167.55B | 232.66B | |
Enterprise value | 98.7B | 261.42B | 135.43B | 309.56B | 233.03B | |
P/E ratio | -12.61 | 1.2 | 3.33 | 3.98 | 14.83 | |
Price to sales ratio | 0.37 | 0.36 | 0.64 | 0.87 | 0.94 | |
POCF ratio | 16.5 | 15.55 | 22.96 | 28.3 | 34.8 | |
PFCF ratio | 16.5 | 15.55 | 22.96 | 28.3 | 34.8 | |
P/B Ratio | 1.21 | 0.93 | 1.37 | 1.4 | 1.95 | |
PTB ratio | 1.21 | 0.93 | 1.37 | 1.4 | 1.95 | |
EV to sales | 0.37 | 1.03 | 0.64 | 1.61 | 0.94 | |
Enterprise value over EBITDA | 248.74 | 7.96 | 7.41 | 16.21 | 26.79 | |
EV to operating cash flow | 16.56 | 44.13 | 23.03 | 52.3 | 34.86 | |
EV to free cash flow | 16.56 | 44.13 | 23.03 | 52.3 | 34.86 | |
Earnings yield | -0.02 | 0.21 | 0.08 | 0.06 | 0.02 | |
Free cash flow yield | 0.06 | 0.06 | 0.04 | 0.04 | 0.03 | |
Debt to equity | 0 | 1.72 | 0 | 1.19 | 0 | |
Debt to assets | 0 | 0.48 | 0 | 0.4 | 0 | |
Net debt to EBITDA | 0.95 | 5.15 | 0.02 | 7.44 | 0.04 | |
Current ratio | 0 | 0.99 | 0 | 1.07 | 0 | |
Interest coverage | 0.12 | 13.79 | 6.61 | 6.14 | 3.18 | |
Income quality | -3.06 | 0.31 | 0.58 | 0.56 | 1.71 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.01 | 0 | 0.01 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 34.11 | 117.58 | 85.63 | 95.87 | 58.54 | |
ROIC | 0 | 0.11 | 0.12 | 0.05 | 0.05 | |
Return on tangible assets | 0 | 0.06 | 0 | 0.03 | 0 | |
Graham Net | 0.22 | -104.85 | 0.22 | -93.65 | 0.21 | |
Working capital | 378.6M | -1.34B | 389.2M | 8.03B | 374.3M | |
Tangible asset value | 0 | 94.82B | 0 | 115.49B | 0 | |
Net current asset value | 378.6M | -133.65B | 389.2M | -107.63B | 374.3M | |
Invested capital | 0 | 1.72 | 0 | 1.19 | 0 | |
Average receivables | 21.95B | 23.18B | 23.18B | 20B | 20B | |
Average payables | 40.79B | 30.84B | 30.84B | 32.01B | 32.01B | |
Average inventory | 47.91B | 33.88B | 33.88B | 42.05B | 42.05B | |
Days sales outstanding | 0 | 16.43 | 0 | 18.72 | 0 | |
Days payables outstanding | 0 | 25.79 | 0 | 35.29 | 0 | |
Days of inventory on hand | 0 | 28.33 | 0 | 46.36 | 0 | |
Receivables turnover | 0 | 5.48 | 0 | 4.81 | 0 | |
Payables turnover | 0 | 3.49 | 0 | 2.55 | 0 | |
Inventory turnover | 0 | 3.18 | 0 | 1.94 | 0 | |
ROE | -0.02 | 0.19 | 0.1 | 0.09 | 0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
MRPL.NS Frequently Asked Questions
What is Mangalore Refinery and Petrochemicals Limited stock symbol ?
Mangalore Refinery and Petrochemicals Limited is a IN stock and trading under the symbol MRPL.NS
What is Mangalore Refinery and Petrochemicals Limited stock quote today ?
Mangalore Refinery and Petrochemicals Limited stock price is $230.45 today.
Is Mangalore Refinery and Petrochemicals Limited stock public?
Yes, Mangalore Refinery and Petrochemicals Limited is a publicly traded company.